Indiana Clinical and Translational Sciences Institute

印第安纳临床与转化科学研究所

• 批准号: 10622172
• 负责人: Sharon M Moe
• 金额: $ 547.47万
• 依托单位: INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-05-01 至 2030-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10622172
• 关键词: 3D Print; Abbreviations; Acceleration; Address; Attention; Award; COVID-19; COVID-19 pandemic; COVID-19 vaccine; Clinical Data; Clinical Research; Clinical Sciences; Collaborations; Collection; Communication; Communities; County; Data Sources; Development; Disparate; Ecosystem; Education; Elements; Engineering; Environment; Ethics; Evidence based intervention; Evidence based practice; Face; Family; Federally Qualified Health Center; Fostering; Foundations; Funding; Government; Government Agencies; Health; Health Personnel; Health system; Healthcare; Healthcare Systems; Hospitals; Hour; Human; Indiana; Informatics; Infrastructure; Institution; Institutional Review Boards; International; Journals; Knowledge; Mind; Mission; Outcome; Participant; Patient Care; Patients; Peer Review; Play; Population Heterogeneity; Process; Public Health; Public Health Informatics; Publications; Recommendation; Recording of previous events; Research; Research Personnel; Resources; Role; Rural; Science; Scientist; Services; Social Work; System; Touch sensation; Training; Training Programs; Training and Education; Translational Research; Trust; Underserved Population; Universities; Workforce Development; biobank; care providers; catalyst; clinical practice; clinical translation; community college; community engagement; community organizations; coronavirus disease; dashboard; distrust; diversity and inclusion; empowerment; equity, diversity, and inclusion; health care service organization; health disparity; health equity; implementation strategy; improved; innovation; marginalized population; medical schools; member; novel strategies; pandemic disease; personal protective equipment; policy recommendation; programs; public trust; research and development; response; success; trustworthiness; vaccine trial

PROJECT SUMMARY/ABSTRACT The Indiana Clinical and Translational Sciences Institute (Indiana CTSI) was created in 2008 as a statewide partnership to accelerate clinical and translational research by the three research universities, Indiana, Purdue and Notre Dame, with partner health care systems and providers, community and patient stakeholders, local foundations, corporate and government partners. The mission of the Indiana CTSI is to bring together Indiana's brightest minds to solve the most pressing health challenges by serving as the statewide catalyst for clinical and translational research and improve human health across Indiana, the nation and beyond. The Indiana CTSI fosters a collaborative research environment, provides resources and services to conduct the highest-quality clinical and translational research, offers education and training programs to build a robust translational workforce, engages our community as a partner at all levels, identifies and removes barriers to research through translational science approaches, and functions as an exemplary member of the national CTSA network. The CTSI plans to accomplish its mission through five Specific Aims: Aim 1. Accelerate training and research opportunities across the state to create a diverse and trusted translational research workforce that demonstrates respect, responsibility, and cultural humility through effective communication, team science and authentic stakeholder engagement. Aim 2. Enrich and integrate our network of patient, health care, corporate, community, and government agency partners to better engage and empower underserved populations across Indiana, focusing on regions and groups with poorest health outcomes. Aim 3. Enhance access to I-CTSI programs and services to facilitate and expedite impactful clinical and translational research that is innovative, inclusive, collaborative, and ethical, and effectively disseminates and implements evidence-based interventions across the state. Aim 4. Identify barriers, create solutions, and disseminate novel approaches for best practices of clinical and translational science through community and stakeholder engagement, pilot funding, and a trustworthy and integrated translational research ecosystem. Aim 5. Leverage our statewide informatics platform and innovative analytic capabilities to harmonize disparate data sources in collaboration with health systems across the state and with deliberate inclusion from diverse populations to advance health equity. In 2030, at the end of this seven- year renewal funding period, we envision the I-CTSI will transform our statewide research ecosystem with deliberate attention to diversity and inclusion in our partnerships, workforce development and research engagement. We will accelerate innovation and rapidly implement evidence into practice in order to advance health equity.

项目摘要/摘要 印第安纳州临床和转化科学研究所（印第安纳州CTSI）于2008年创建为全州 印第安纳州三所研究的三所研究型临床和翻译研究的合作伙伴关系 与巴黎圣母院，合作伙伴医疗保健系统以及提供者，社区和患者利益相关者，当地 基金会，公司和政府合作伙伴。印第安纳州CTSI的使命是将印第安纳州的任务汇集在一起 通过作为临床和 转化研究并改善印第安纳州，国家及其他地区的人类健康。印第安纳州CTSI 培养协作研究环境，提供资源和服务以进行最高质量 临床和翻译研究，提供教育和培训计划，以建立强大的翻译 劳动力，使我们的社区成为各个层面的合作伙伴，确定并消除了通过 转化科学方法，并充当国家CTSA网络的典范成员。这 CTSI计划通过五个特定目标来完成其使命：目标1。加速培训和研究 全州的机会创建一个多样化和值得信赖的翻译研究人员 通过有效的沟通，团队科学和真实的尊重，责任和文化谦卑 利益相关者的参与。目标2。丰富和整合我们的患者，医疗保健，公司，社区， 政府机构合作伙伴可以更好地参与和授权印第安纳州服务不足的人口 专注于健康结果最差的地区和群体。目标3。增强对I-CTSI计划的访问权限和 促进和加快有影响力的临床和转化研究的服务，这些研究具有创新，包容性， 协作，道德，并有效地传播并实施基于证据的干预措施 状态。目标4。确定障碍，创建解决方案并传播新颖的方法，以实现最佳临床实践 以及通过社区和利益相关者的参与，飞行员资金以及值得信赖的和可信赖的转化科学 综合翻译研究生态系统。目标5。利用我们全州信息平台和创新 与全州卫生系统合作协调数据源的分析能力 并有意纳入不同人群以提高健康公平。 2030年，在这七个结束时 年份续签期限，我们设想I-CTSI将通过 故意关注多样性和包容我们的伙伴关系，劳动力发展和研究 订婚。我们将加速创新并迅速实施证据，以促进 健康平等。